Skip to content

Identification and Clinical Treatment of Severe novel coronavirus pneumonia (COVID-19) Patients

Identification and Clinical Treatment of Severe novel coronavirus pneumonia (COVID-19) Patients

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030322
Enrollment
Unknown
Registered
2020-02-28
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Light and common type group:Conventional treatment
Severe group:Conventional treatment
Western medicine treatment group:Give routine western medicine treatment
Chinese and western medicine combined treatment group:Traditional Chinese medicine is combined with conventional western medicine treatment.
Non-invasive mechanical ventilation group:Give noninvasive mechanical ventilation and respiratory support
Nasal high flow oxygen therapy group:Give nasal high flow oxygen therapy respiratory support

Sponsors

Xinyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: According to the "Diagnosis and Treatment Plan for Pneumonia Infected in novel coronavirus (Trial Version 6)" issued by the General Office of the State Health Committee of the People's Republic of China, newly diagnosed patients with pneumonia have been diagnosed. Clinical classification: (1) mild: clinical symptoms are mild, and no pneumonia is found on imaging; (2) Common type: with fever, respiratory tract and other symptoms, pneumonia can be seen on imaging; (3) Heavy duty. Comply with any of the following: 1. shortness of breath, RR>=30 times/min; 2. In the resting state, oxygen saturation 50% within 24-48 hours should be managed according to heavy duty; 4. Critical type: one of the following conditions is met: (1) Respiratory failure occurs and mechanical ventilation is required; (2) Shock; (3) ICU monitoring and treatment are required for patients with other organ failure.

Exclusion criteria

Exclusion criteria: 1. Patients with serious heart and lung, liver and kidney functions and central nervous system diseases; 2. Pregnant or lactating patients.

Design outcomes

Primary

MeasureTime frame
Epidemiological and clinical characteristics;

Countries

China

Contacts

Public ContactLu Yibin

Xinyang Central Hospital

luyb6810@163.com+86 13937642780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026